PEL

CCI approves proposed combination involving acquisition of 20% of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co.) by CA Clover Intermediate II Investments (Curie)

The Competition Commission of India (CCI) approves proposed combination involving acquisition of 20% of the issued and paid-up equity share…

Read More »